ABSTRACTS
Amos Burke, G. A., Locatelli, Franco, Kabickova, Edita, Beishuizen, Auke, Tacylidiz, Nurdan, Uyttebroeck, Anne, Kang, Hyoungjin, Luisi, Flavio, Minard-Colin, Veronique, Burkhardt, Birgit, Tamegnon, Monelle, Sun, Steven, Poggesi, Italo, Curtis, Madeliene, Deshpande, Sanjay, Nottage, Kerri, Howes, Angela, Cairo, Mitchell
Abstract
Background: Core binding factor acute myeloid leukemia (AML) is a common type of pediatric AML characterized by inv(16) or t (8;21) lesions that inhibit the function of the core binding factor complex.
Topics & Concepts
MedicineMyeloid leukemiaCore binding factorCancer researchLeukemiaMyeloidFunction (biology)Lymphoblastic LeukemiaOncologyCore (optical fiber)Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsRetinoids in leukemia and cellular processes